Georgios Terzis Buys 168,135 Shares of Cosmos Health (NASDAQ:COSM) Stock

Cosmos Health Inc. (NASDAQ:COSM) CFO Georgios Terzis purchased 168,135 shares of the firm’s stock in a transaction on Tuesday, June 16th. The stock was acquired at an average cost of $0.25 per share, for a total transaction of $42,033.75. Following the completion of the purchase, the chief financial officer owned 2,235,398 shares in the company, valued at $558,849.50. The trade was a 8.13% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Cosmos Health Stock Down 11.9%

COSM opened at $0.21 on Friday. Cosmos Health Inc. has a 12 month low of $0.18 and a 12 month high of $1.32. The business has a 50-day moving average of $0.30 and a two-hundred day moving average of $0.39. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.08 and a quick ratio of 0.92. The stock has a market capitalization of $13.22 million, a price-to-earnings ratio of -0.33 and a beta of 4.79.

Cosmos Health (NASDAQ:COSM) last announced its quarterly earnings data on Thursday, May 21st. The company reported ($0.06) earnings per share for the quarter, hitting the consensus estimate of ($0.06). Cosmos Health had a negative net margin of 30.41% and a negative return on equity of 52.85%. The business had revenue of $18.40 million for the quarter, compared to analyst estimates of $17.93 million. On average, research analysts expect that Cosmos Health Inc. will post -0.06 earnings per share for the current year.

Institutional Investors Weigh In On Cosmos Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Renaissance Technologies LLC lifted its stake in shares of Cosmos Health by 16.7% in the 1st quarter. Renaissance Technologies LLC now owns 390,500 shares of the company’s stock valued at $124,000 after purchasing an additional 55,925 shares in the last quarter. Citadel Advisors LLC increased its position in Cosmos Health by 133.1% during the 3rd quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock worth $250,000 after purchasing an additional 128,776 shares in the last quarter. Finally, XTX Topco Ltd increased its position in Cosmos Health by 52.1% during the 4th quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock worth $50,000 after purchasing an additional 34,117 shares in the last quarter. 12.61% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Cosmos Health in a research note on Monday. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Cosmos Health presently has an average rating of “Sell”.

Cosmos Health Company Profile

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.